Jazz Pharmaceuticals plc

JAZZ

$237.95

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $15,446,423,552.00

EPSttm : 14.61

Jazz Pharmaceuticals plc

$237.95

0.71%

$1.67

JAZZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.5

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

1.56

EPS Last/This Y

30.87

EPS This/Next Y

0.74

Price

238.02

Target Price

296.2

Analyst Recom

1.43

Performance Q

3.45

Upside

-20.8%

Beta

0.36

Ticker: JAZZ

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	JAZZ	244.57	0.83	0.12	6068
2026-08-31	JAZZ	250.8	0.83	0.16	6055
2026-09-02	JAZZ	245.42	0.83	0.30	6096
2026-09-03	JAZZ	247.49	0.83	0.89	6102
2026-09-04	JAZZ	246.97	0.83	0.26	6121
2026-09-08	JAZZ	240.03	0.83	0.58	6114
2026-09-09	JAZZ	241.37	0.83	0.35	6146
2026-09-10	JAZZ	240.37	0.84	0.52	6189
2026-09-11	JAZZ	245.83	0.84	0.80	6242
2026-09-14	JAZZ	245.9	0.84	0.56	6250
2026-09-15	JAZZ	240.79	0.84	0.11	6274
2026-09-16	JAZZ	244.56	0.84	0.00	6293
2026-09-17	JAZZ	243.87	0.84	0.13	6293
2026-09-18	JAZZ	240.9	0.82	0.77	6285
2026-09-21	JAZZ	241.62	0.49	0.14	3268
2026-09-22	JAZZ	240.63	0.48	0.01	3302
2026-09-23	JAZZ	235.03	0.43	14.00	3569
2026-09-24	JAZZ	236.18	0.72	0.47	4359
2026-09-25	JAZZ	238.05	0.71	0.00	4367
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	JAZZ	245.13	-20.4	194.8	25.03
2026-08-31	JAZZ	250.50	-20.4	242.2	25.03
2026-09-01	JAZZ	243.71	-20.4	190.9	25.03
2026-09-02	JAZZ	245.52	-20.4	228.0	25.03
2026-09-03	JAZZ	247.02	-20.4	373.7	25.03
2026-09-04	JAZZ	246.88	-20.4	362.9	25.03
2026-09-08	JAZZ	239.84	-20.5	334.8	25.03
2026-09-09	JAZZ	241.32	-20.5	372.1	25.03
2026-09-10	JAZZ	240.50	-20.5	362.5	25.03
2026-09-11	JAZZ	245.89	-20.5	391.3	25.03
2026-09-14	JAZZ	245.98	-20.5	366.8	25.03
2026-09-15	JAZZ	240.85	-20.4	343.5	25.03
2026-09-16	JAZZ	240.85	-20.4	343.5	25.03
2026-09-17	JAZZ	243.94	-20.4	367.5	25.03
2026-09-18	JAZZ	240.96	-20.4	353.5	25.03
2026-09-21	JAZZ	241.62	-20.4	370.3	25.03
2026-09-22	JAZZ	240.55	-20.4	362.3	25.03
2026-09-23	JAZZ	234.88	-20.4	339.5	25.03
2026-09-24	JAZZ	236.20	-20.4	371.8	25.03
2026-09-25	JAZZ	238.02	-20.4	374.4	25.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	JAZZ	-4.22	-1.98	5.81
2026-08-31	JAZZ	-4.22	-1.72	5.81
2026-09-01	JAZZ	-6.76	-1.72	5.81
2026-09-02	JAZZ	-6.76	-1.72	5.81
2026-09-03	JAZZ	-4.76	-1.72	5.81
2026-09-04	JAZZ	-4.76	-1.72	5.81
2026-09-08	JAZZ	-4.56	-1.66	5.81
2026-09-09	JAZZ	-4.64	-1.66	5.81
2026-09-10	JAZZ	-4.59	-1.66	5.81
2026-09-11	JAZZ	-4.82	-1.66	7.42
2026-09-14	JAZZ	-4.82	-1.69	7.42
2026-09-15	JAZZ	-4.86	-1.69	7.42
2026-09-16	JAZZ	-4.86	-1.69	7.42
2026-09-17	JAZZ	-4.86	-1.69	7.42
2026-09-18	JAZZ	-4.86	-1.69	7.42
2026-09-21	JAZZ	-4.87	-1.62	7.42
2026-09-23	JAZZ	-4.87	-1.62	7.42
2026-09-24	JAZZ	-4.87	-1.62	7.42
2026-09-25	JAZZ	-4.87	-1.62	7.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

4.89

Avg. EPS Est. Current Quarter

6.47

Avg. EPS Est. Next Quarter

6.45

Insider Transactions

-4.87

Institutional Transactions

-1.62

Beta

0.36

Average Sales Estimate Current Quarter

1208

Average Sales Estimate Next Quarter

1231

Fair Value

341.33

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.6

Max Drawdown 5-Year %

-42

Target Price

296.2

P/E

16.41

Forward P/E

9.24

PEG

0.18

P/S

3.36

P/B

3.21

P/Free Cash Flow

9.71

EPS

14.5

Average EPS Est. Cur. Y

25.03

EPS Next Y. (Est.)

25.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.45

Relative Volume

1.26

Return on Equity vs Sector %

-6.7

Return on Equity vs Industry %

12.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

374.4

◆ JAZZ Healthcare

$237.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

23/25

Volume

4/15

Valuation

15/20

TP/AR

4/10

Options

5/10

RSI

42.5

Range 1M

21.1%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

20/30

Estimates

8/20

Inst/Vol

4/15

Options

4/10

EPS Yr

197.8%

EPS NY

3.1%

52W%

79.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +38.3% upside

Quality

22/30

Valuation

20/30

Growth

14/25

Stability

4/10

LT Trend

2/5

Upside

+38.3%

Quality

MoS

43%

JAZZ — P/E HistoricalBiotechnology

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., Werewolf Therapeutics, Inc; and AbCellera Biologics Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$237.95

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $15,446,423,552.00

EPSttm : 14.61

Jazz Pharmaceuticals plc

$237.95

0.71%

$1.67

JAZZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.5

Margin Of Safety %

Put/Call OI Ratio

0.71

EPS Next Q Diff

1.56

EPS Last/This Y

30.87

EPS This/Next Y

0.74

Price

238.02

Target Price

296.2

Analyst Recom

1.43

Performance Q

3.45

Upside

-20.8%

Beta

0.36

Ticker: JAZZ

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	JAZZ	244.57	0.83	0.12	6068
2026-08-31	JAZZ	250.8	0.83	0.16	6055
2026-09-02	JAZZ	245.42	0.83	0.30	6096
2026-09-03	JAZZ	247.49	0.83	0.89	6102
2026-09-04	JAZZ	246.97	0.83	0.26	6121
2026-09-08	JAZZ	240.03	0.83	0.58	6114
2026-09-09	JAZZ	241.37	0.83	0.35	6146
2026-09-10	JAZZ	240.37	0.84	0.52	6189
2026-09-11	JAZZ	245.83	0.84	0.80	6242
2026-09-14	JAZZ	245.9	0.84	0.56	6250
2026-09-15	JAZZ	240.79	0.84	0.11	6274
2026-09-16	JAZZ	244.56	0.84	0.00	6293
2026-09-17	JAZZ	243.87	0.84	0.13	6293
2026-09-18	JAZZ	240.9	0.82	0.77	6285
2026-09-21	JAZZ	241.62	0.49	0.14	3268
2026-09-22	JAZZ	240.63	0.48	0.01	3302
2026-09-23	JAZZ	235.03	0.43	14.00	3569
2026-09-24	JAZZ	236.18	0.72	0.47	4359
2026-09-25	JAZZ	238.05	0.71	0.00	4367
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	JAZZ	245.13	-20.4	194.8	25.03
2026-08-31	JAZZ	250.50	-20.4	242.2	25.03
2026-09-01	JAZZ	243.71	-20.4	190.9	25.03
2026-09-02	JAZZ	245.52	-20.4	228.0	25.03
2026-09-03	JAZZ	247.02	-20.4	373.7	25.03
2026-09-04	JAZZ	246.88	-20.4	362.9	25.03
2026-09-08	JAZZ	239.84	-20.5	334.8	25.03
2026-09-09	JAZZ	241.32	-20.5	372.1	25.03
2026-09-10	JAZZ	240.50	-20.5	362.5	25.03
2026-09-11	JAZZ	245.89	-20.5	391.3	25.03
2026-09-14	JAZZ	245.98	-20.5	366.8	25.03
2026-09-15	JAZZ	240.85	-20.4	343.5	25.03
2026-09-16	JAZZ	240.85	-20.4	343.5	25.03
2026-09-17	JAZZ	243.94	-20.4	367.5	25.03
2026-09-18	JAZZ	240.96	-20.4	353.5	25.03
2026-09-21	JAZZ	241.62	-20.4	370.3	25.03
2026-09-22	JAZZ	240.55	-20.4	362.3	25.03
2026-09-23	JAZZ	234.88	-20.4	339.5	25.03
2026-09-24	JAZZ	236.20	-20.4	371.8	25.03
2026-09-25	JAZZ	238.02	-20.4	374.4	25.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	JAZZ	-4.22	-1.98	5.81
2026-08-31	JAZZ	-4.22	-1.72	5.81
2026-09-01	JAZZ	-6.76	-1.72	5.81
2026-09-02	JAZZ	-6.76	-1.72	5.81
2026-09-03	JAZZ	-4.76	-1.72	5.81
2026-09-04	JAZZ	-4.76	-1.72	5.81
2026-09-08	JAZZ	-4.56	-1.66	5.81
2026-09-09	JAZZ	-4.64	-1.66	5.81
2026-09-10	JAZZ	-4.59	-1.66	5.81
2026-09-11	JAZZ	-4.82	-1.66	7.42
2026-09-14	JAZZ	-4.82	-1.69	7.42
2026-09-15	JAZZ	-4.86	-1.69	7.42
2026-09-16	JAZZ	-4.86	-1.69	7.42
2026-09-17	JAZZ	-4.86	-1.69	7.42
2026-09-18	JAZZ	-4.86	-1.69	7.42
2026-09-21	JAZZ	-4.87	-1.62	7.42
2026-09-23	JAZZ	-4.87	-1.62	7.42
2026-09-24	JAZZ	-4.87	-1.62	7.42
2026-09-25	JAZZ	-4.87	-1.62	7.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

4.89

Avg. EPS Est. Current Quarter

6.47

Avg. EPS Est. Next Quarter

6.45

Insider Transactions

-4.87

Institutional Transactions

-1.62

Beta

0.36

Average Sales Estimate Current Quarter

1208

Average Sales Estimate Next Quarter

1231

Fair Value

341.33

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.6

Max Drawdown 5-Year %

-42

Target Price

296.2

P/E

16.41

Forward P/E

9.24

PEG

0.18

P/S

3.36

P/B

3.21

P/Free Cash Flow

9.71

EPS

14.5

Average EPS Est. Cur. Y

25.03

EPS Next Y. (Est.)

25.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.45

Relative Volume

1.26

Return on Equity vs Sector %

-6.7

Return on Equity vs Industry %

12.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

374.4

◆ JAZZ Healthcare

$237.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

23/25

Volume

4/15

Valuation

15/20

TP/AR

4/10

Options

5/10

RSI

42.5

Range 1M

21.1%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

20/30

Estimates

8/20

Inst/Vol

4/15

Options

4/10

EPS Yr

197.8%

EPS NY

3.1%

52W%

79.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +38.3% upside

Quality

22/30

Valuation

20/30

Growth

14/25

Stability

4/10

LT Trend

2/5

Upside

+38.3%

Quality

MoS

43%

JAZZ — P/E HistoricalBiotechnology

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2890

JAZZ

Latest News

—

Caricamento notizie per JAZZ…

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y